GlassScriptPhysician profile
Suzanne Ne Anderson
NPI 1982615449
$2,089.38
in general payments reported to CMS, 2019-2025
11 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $372 · 2020: $38.80 · 2021: $175 · 2023: $537 · 2024: $803 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,504.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $559.65 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $371.48 | 2023-2025 | Precision 1, Precision7, Total30 |
| Sun Pharmaceutical Industries INC. | $237.52 | 2023-2024 | Cequa |
| Johnson & Johnson Surgical Vision, INC. | $229.02 | 2019 | |
| Coopervision INC. | $222.71 | 2019-2024 | Misight Contact Lens, Cvi Contact Lens |
| Amgen INC. | $124.99 | 2024 | Tepezza |
| Dompe US, INC. | $122.13 | 2024 | Oxervate |
| Abbvie INC. | $116.71 | 2024 | |
| Rxsight INC | $50.00 | 2021 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Glaukos Corporation | $16.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.